BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 184 filers reported holding BLUEBIRD BIO INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $39,255 | +8.1% | 11,450 | +4.6% | 0.00% | 0.0% |
Q1 2023 | $36,307 | -64.3% | 10,950 | -25.5% | 0.00% | -62.5% |
Q4 2022 | $101,610 | -97.1% | 14,690 | -67.4% | 0.01% | -97.3% |
Q3 2022 | $3,538,000 | +8127.9% | 45,071 | +332.1% | 0.29% | +9633.3% |
Q2 2022 | $43,000 | -24.6% | 10,430 | -11.8% | 0.00% | -25.0% |
Q1 2022 | $57,000 | -58.7% | 11,830 | -14.5% | 0.00% | -55.6% |
Q4 2021 | $138,000 | -89.5% | 13,830 | -69.4% | 0.01% | -89.8% |
Q3 2021 | $1,310,000 | +92.4% | 45,234 | +766.4% | 0.09% | +95.6% |
Q2 2021 | $681,000 | -41.7% | 5,221 | -83.7% | 0.04% | -45.8% |
Q1 2021 | $1,168,000 | +276.8% | 32,023 | +930.7% | 0.08% | +295.2% |
Q4 2020 | $310,000 | – | 3,107 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
Summit X, LLC | 103,424 | $651,000 | 0.19% |